SEBIVO

This brand name is authorized in Estonia, Hong Kong, Lithuania, Poland, Romania, Singapore

Active ingredients

The drug SEBIVO contains one active pharmaceutical ingredient (API):

1 Telbivudine
UNII 2OC4HKD3SF - TELBIVUDINE

Telbivudine is a synthetic thymidine nucleoside analogue with activity against HBV DNA polymerase. It is efficiently phosphorylated by cellular kinases to the active triphosphate form. Incorporation of telbivudine-5'-triphosphate into viral DNA causes DNA chain termination, resulting in inhibition of HBV replication.

Read about Telbivudine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SEBIVO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J05AF11 Telbivudine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
Discover more medicines within J05AF11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1294781, 1367940, 1437836
Country: HK Department of Health Drug Office Identifier(s): 55624
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1030594, 1030595, 1036163
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100206276, 100219422
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64471001, W64471002
Country: SG Health Sciences Authority Identifier(s): 13304P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.